世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ビタミンK2の世界市場調査報告書 2022年

ビタミンK2の世界市場調査報告書 2022年


Global Vitamin K2 Market Research Report 2022

ビタミンK2の世界市場は、2021年の1億5410万米ドルから2028年末には2億7960万米ドルに達し、予測期間中に7.7%のCAGRを記録するものと思われます。 本レポートでは、世界レベル、地域レベル、企業レベルでのビタ... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年7月21日 US$2,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

ビタミンK2の世界市場は、2021年の1億5410万米ドルから2028年末には2億7960万米ドルに達し、予測期間中に7.7%のCAGRを記録するものと思われます。
本レポートでは、世界レベル、地域レベル、企業レベルでのビタミンK2の数量と価値に焦点を当てています。世界的な視点から、過去のデータと将来の見通しを分析することで、ビタミンK2の全体的な市場規模を表現しています。地域的には、このレポートはいくつかの主要地域に焦点を当てています。北米、欧州、中国、日本、インドなどです。
ビタミンK2の世界市場セグメント分析
この調査レポートには、地域（国）別、企業別、タイプ別、用途別の具体的なセグメントが含まれています。2017年から2028年までの歴史的期間と予測期間における売上高と収益に関する情報を提供しています。セグメントを理解することは、市場成長を助ける様々な要因の重要性を特定するのに役立ちます。

世界のビタミンK2市場セグメント分析
調査レポートには、地域（国）別、メーカー別、タイプ別、用途別の具体的なセグメントが含まれています。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。

企業別
グノーシス バイ レザフレ
カッパバイオサイエンス
グァンドン・サンゲン
ビリディス・バイオファーマ
IFFヘルス（フルタロム）
ヴェスタ・ニュートラ
ジーンファーマバイオテクノロジー
上海レゾン バイオテック
広東省グッドセンド社
シービオバイオテック
協和発酵

種類別セグメント
ビタミンMK-7
ビタミンMK-4
その他(MK-9等)

用途別セグメント
栄養分野
食品・飲料

地域別消費量
北アメリカ
米国
カナダ
アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
その他の欧州
南米
メキシコ
ブラジル
南米のその他



ページTOPに戻る


目次

1 VITAMIN K2 MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF VITAMIN K2 1
1.2 VITAMIN K2 SEGMENT BY TYPE 2
1.2.1 GLOBAL VITAMIN K2 SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 VITAMIN MK-7 3
1.2.3 VITAMIN MK-4 3
1.2.4 OTHER (MK-9 ETC.) 4
1.3 VITAMIN K2 SEGMENT BY APPLICATION 4
1.3.1 GLOBAL VITAMIN K2 SALES COMPARISON BY APPLICATION (2022-2028) 4
1.3.2 NUTRITION 5
1.3.3 FOOD AND BEVERAGE 5
1.4 GLOBAL VITAMIN K2 MARKET SIZE ESTIMATES AND FORECASTS 6
1.4.1 GLOBAL VITAMIN K2 REVENUE 2017-2028 6
1.4.2 GLOBAL VITAMIN K2 SALES 2017-2028 7
1.4.3 VITAMIN K2 MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 8
2 VITAMIN K2 MARKET COMPETITION BY MANUFACTURERS 9
2.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 9
2.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 11
2.3 GLOBAL VITAMIN K2 AVERAGE PRICE BY MANUFACTURERS (2017-2022) 13
2.4 MANUFACTURERS VITAMIN K2 MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE 13
2.5 VITAMIN K2 MARKET COMPETITIVE SITUATION AND TRENDS 15
2.5.1 VITAMIN K2 MARKET CONCENTRATION RATE 15
2.5.2 THE GLOBAL 5 LARGEST VITAMIN K2 PLAYERS MARKET SHARE BY REVENUE 15
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 16
3 VITAMIN K2 RETROSPECTIVE MARKET SCENARIO BY REGION 18
3.1 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 18
3.2 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 18
3.3 NORTH AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 19
3.3.1 NORTH AMERICA VITAMIN K2 SALES BY COUNTRY 19
3.3.2 NORTH AMERICA VITAMIN K2 REVENUE BY COUNTRY 20
3.3.3 UNITED STATES 21
3.3.4 CANADA 21
3.4 EUROPE VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 22
3.4.1 EUROPE VITAMIN K2 SALES BY COUNTRY 22
3.4.2 EUROPE VITAMIN K2 REVENUE BY COUNTRY 22
3.4.3 GERMANY 23
3.4.4 FRANCE 24
3.4.5 U.K. 24
3.4.6 ITALY 25
3.4.7 RUSSIA 25
3.5 ASIA PACIFIC VITAMIN K2 MARKET FACTS & FIGURES BY REGION 26
3.5.1 ASIA PACIFIC VITAMIN K2 SALES BY REGION 26
3.5.2 ASIA PACIFIC VITAMIN K2 REVENUE BY REGION 26
3.5.3 CHINA 27
3.5.4 JAPAN 28
3.5.5 SOUTH KOREA 28
3.5.6 INDIA 29
3.5.7 AUSTRALIA 29
3.5.8 SOUTHEAST ASIA 30
3.6 LATIN AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 30
3.6.1 LATIN AMERICA VITAMIN K2 SALES BY COUNTRY 30
3.6.2 LATIN AMERICA VITAMIN K2 REVENUE BY COUNTRY 31
3.6.3 MEXICO 32
3.6.4 BRAZIL 32
3.6.5 ARGENTINA 33
3.7 MIDDLE EAST AND AFRICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 33
3.7.1 MIDDLE EAST AND AFRICA VITAMIN K2 SALES BY COUNTRY 33
3.7.2 MIDDLE EAST AND AFRICA VITAMIN K2 REVENUE BY COUNTRY 34
3.7.3 TURKEY 35
3.7.4 SAUDI ARABIA 35
3.7.5 UAE 36
4 VITAMIN K2 HISTORIC MARKET ANALYSIS BY TYPE 37
4.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY TYPE (2017-2022) 37
4.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY TYPE (2017-2022) 38
4.3 GLOBAL VITAMIN K2 PRICE BY TYPE (2017-2022) 38
5 VITAMIN K2 HISTORIC MARKET ANALYSIS BY APPLICATION 39
5.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY APPLICATION (2017-2022) 39
5.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY APPLICATION (2017-2022) 39
5.3 GLOBAL VITAMIN K2 PRICE BY APPLICATION (2017-2022) 40
6 KEY COMPANIES PROFILED 41
6.1 GNOSIS BY LESAFFRE 41
6.1.1 GNOSIS CORPORATION INFORMATION 41
6.1.2 GNOSIS DESCRIPTION AND BUSINESS OVERVIEW 41
6.1.3 GNOSIS VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 42
6.1.4 GNOSIS VITAMIN K2 PRODUCT PORTFOLIO 42
6.1.5 GNOSIS RECENT DEVELOPMENTS/UPDATES 44
6.2 KAPPA BIOSCIENCE 45
6.2.1 KAPPA BIOSCIENCE CORPORATION INFORMATION 45
6.2.2 KAPPA BIOSCIENCE DESCRIPTION AND BUSINESS OVERVIEW 45
6.2.3 KAPPA BIOSCIENCE VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 46
6.2.4 KAPPA BIOSCIENCE VITAMIN K2 PRODUCT PORTFOLIO 46
6.2.5 KAPPA BIOSCIENCE RECENT DEVELOPMENTS/UPDATES 47
6.3 GUANDONG SUNGEN 47
6.3.1 GUANDONG SUNGEN CORPORATION INFORMATION 48
6.3.2 GUANDONG SUNGEN DESCRIPTION AND BUSINESS OVERVIEW 48
6.3.3 GUANDONG SUNGEN VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 49
6.3.4 GUANDONG SUNGEN VITAMIN K2 PRODUCT PORTFOLIO 49
6.3.5 GUANDONG SUNGEN RECENT DEVELOPMENTS/UPDATES 49
6.4 VIRIDIS BIOPHARMA 50
6.4.1 VIRIDIS BIOPHARMA CORPORATION INFORMATION 50
6.4.2 VIRIDIS BIOPHARMA DESCRIPTION AND BUSINESS OVERVIEW 51
6.4.3 VIRIDIS BIOPHARMA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 51
6.4.4 VIRIDIS BIOPHARMA VITAMIN K2 PRODUCT PORTFOLIO 52
6.5 IFF HEALTH (FRUTAROM) 52
6.5.1 FRUTAROM CORPORATION INFORMATION 52
6.5.2 FRUTAROM DESCRIPTION AND BUSINESS OVERVIEW 53
6.5.3 FRUTAROM VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 53
6.5.4 FRUTAROM VITAMIN K2 PRODUCT PORTFOLIO 54
6.6 VESTA NUTRA 54
6.6.1 VESTA NUTRA CORPORATION INFORMATION 55
6.6.2 VESTA NUTRA DESCRIPTION AND BUSINESS OVERVIEW 55
6.6.3 VESTA NUTRA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 55
6.6.4 VESTA NUTRA VITAMIN K2 PRODUCT PORTFOLIO 56
6.7 GENEFERM BIOTECHNOLOGY 56
6.7.1 GENEFERM BIOTECHNOLOGY CORPORATION INFORMATION 56
6.7.2 GENEFERM BIOTECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW 57
6.7.3 GENEFERM BIOTECHNOLOGY VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 57
6.7.4 GENEFERM BIOTECHNOLOGY VITAMIN K2 PRODUCT PORTFOLIO 58
6.8 SHANGHAI RESON BIOTECH 58
6.8.1 SHANGHAI RESON BIOTECH CORPORATION INFORMATION 59
6.8.2 SHANGHAI RESON BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 59
6.8.3 SHANGHAI RESON BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 59
6.8.4 SHANGHAI RESON BIOTECH VITAMIN K2 PRODUCT PORTFOLIO 60
6.9 GUANGDONG GOODSCEND 61
6.9.1 GUANGDONG GOODSCEND CORPORATION INFORMATION 61
6.9.2 GUANGDONG GOODSCEND DESCRIPTION AND BUSINESS OVERVIEW 61
6.9.3 GUANGDONG GOODSCEND VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 62
6.9.4 GUANGDONG GOODSCEND VITAMIN K2 PRODUCT PORTFOLIO 62
6.10 SEEBIO BIOTECH 63
6.10.1 SEEBIO BIOTECH CORPORATION INFORMATION 64
6.10.2 SEEBIO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 64
6.10.3 SEEBIO BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 64
6.10.4 SEEBIO BIOTECH VITAMIN K2 PRODUCT PORTFOLIO 65
6.11 KYOWA HAKKO 66
6.11.1 KYOWA HAKKO CORPORATION INFORMATION 66
6.11.2 KYOWA HAKKO DESCRIPTION AND BUSINESS OVERVIEW 67
6.11.3 KYOWA HAKKO VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 67
6.11.4 KYOWA HAKKO VITAMIN K2 PRODUCT PORTFOLIO 67
7 VITAMIN K2 MANUFACTURING COST ANALYSIS 69
7.1 VITAMIN K2 KEY RAW MATERIALS ANALYSIS 69
7.1.1 KEY RAW MATERIALS 69
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 69
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 71
7.3 MANUFACTURING PROCESS ANALYSIS OF VITAMIN K2 72
7.4 VITAMIN K2 INDUSTRIAL CHAIN ANALYSIS 73
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 74
8.1 MARKETING CHANNEL 74
8.2 VITAMIN K2 DISTRIBUTORS LIST 74
8.3 VITAMIN K2 CUSTOMERS 76
9 VITAMIN K2 MARKET DYNAMICS 79
9.1 VITAMIN K2 INDUSTRY TRENDS 79
9.2 VITAMIN K2 MARKET DRIVERS 79
9.3 VITAMIN K2 MARKET CHALLENGES 80
9.4 VITAMIN K2 MARKET RESTRAINTS 80
10 GLOBAL MARKET FORECAST 81
10.1 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY TYPE 81
10.1.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY TYPE (2023-2028) 81
10.1.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY TYPE (2023-2028) 81
10.2 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 82
10.2.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY APPLICATION (2023-2028) 82
10.2.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY APPLICATION (2023-2028) 82
10.3 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY REGION 83
10.3.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY REGION (2023-2028) 83
10.3.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY REGION (2023-2028) 83
11 RESEARCH FINDINGS AND CONCLUSION 85
12 METHODOLOGY AND DATA SOURCE 87
12.1 METHODOLOGY/RESEARCH APPROACH 87
12.1.1 RESEARCH PROGRAMS/DESIGN 87
12.1.2 MARKET SIZE ESTIMATION 88
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 89
12.2 DATA SOURCE 90
12.2.1 SECONDARY SOURCES 90
12.2.2 PRIMARY SOURCES 91
12.3 AUTHOR LIST 93
12.4 DISCLAIMER 93

　

ページTOPに戻る


　

Summary

The global Vitamin K2 market will reach to 279.6 million USD by the end of 2028, from the 154.1 million USD in 2021, with a CAGR of 7.7% in the forecast years.
This report focuses on Vitamin K2 volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Vitamin K2 market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, India, etc.
Global Vitamin K2 Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Vitamin K2 Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company
Gnosis by Lesaffre
Kappa Bioscience
Guandong Sungen
Viridis BioPharma
IFF Health (Frutarom)
Vesta Nutra
GeneFerm Biotechnology
Shanghai Reson Biotech
Guangdong Goodscend
Seebio Biotech
Kyowa Hakko

Segment by Type
Vitamin MK-7
Vitamin MK-4
Other (MK-9 etc.)

Segment by Application
Nutrition
Food and Beverage

Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
South America
Mexico
Brazil
Rest of South America



ページTOPに戻る


Table of Contents

1 VITAMIN K2 MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF VITAMIN K2 1
1.2 VITAMIN K2 SEGMENT BY TYPE 2
1.2.1 GLOBAL VITAMIN K2 SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 VITAMIN MK-7 3
1.2.3 VITAMIN MK-4 3
1.2.4 OTHER (MK-9 ETC.) 4
1.3 VITAMIN K2 SEGMENT BY APPLICATION 4
1.3.1 GLOBAL VITAMIN K2 SALES COMPARISON BY APPLICATION (2022-2028) 4
1.3.2 NUTRITION 5
1.3.3 FOOD AND BEVERAGE 5
1.4 GLOBAL VITAMIN K2 MARKET SIZE ESTIMATES AND FORECASTS 6
1.4.1 GLOBAL VITAMIN K2 REVENUE 2017-2028 6
1.4.2 GLOBAL VITAMIN K2 SALES 2017-2028 7
1.4.3 VITAMIN K2 MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 8
2 VITAMIN K2 MARKET COMPETITION BY MANUFACTURERS 9
2.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 9
2.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 11
2.3 GLOBAL VITAMIN K2 AVERAGE PRICE BY MANUFACTURERS (2017-2022) 13
2.4 MANUFACTURERS VITAMIN K2 MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE 13
2.5 VITAMIN K2 MARKET COMPETITIVE SITUATION AND TRENDS 15
2.5.1 VITAMIN K2 MARKET CONCENTRATION RATE 15
2.5.2 THE GLOBAL 5 LARGEST VITAMIN K2 PLAYERS MARKET SHARE BY REVENUE 15
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 16
3 VITAMIN K2 RETROSPECTIVE MARKET SCENARIO BY REGION 18
3.1 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 18
3.2 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 18
3.3 NORTH AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 19
3.3.1 NORTH AMERICA VITAMIN K2 SALES BY COUNTRY 19
3.3.2 NORTH AMERICA VITAMIN K2 REVENUE BY COUNTRY 20
3.3.3 UNITED STATES 21
3.3.4 CANADA 21
3.4 EUROPE VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 22
3.4.1 EUROPE VITAMIN K2 SALES BY COUNTRY 22
3.4.2 EUROPE VITAMIN K2 REVENUE BY COUNTRY 22
3.4.3 GERMANY 23
3.4.4 FRANCE 24
3.4.5 U.K. 24
3.4.6 ITALY 25
3.4.7 RUSSIA 25
3.5 ASIA PACIFIC VITAMIN K2 MARKET FACTS & FIGURES BY REGION 26
3.5.1 ASIA PACIFIC VITAMIN K2 SALES BY REGION 26
3.5.2 ASIA PACIFIC VITAMIN K2 REVENUE BY REGION 26
3.5.3 CHINA 27
3.5.4 JAPAN 28
3.5.5 SOUTH KOREA 28
3.5.6 INDIA 29
3.5.7 AUSTRALIA 29
3.5.8 SOUTHEAST ASIA 30
3.6 LATIN AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 30
3.6.1 LATIN AMERICA VITAMIN K2 SALES BY COUNTRY 30
3.6.2 LATIN AMERICA VITAMIN K2 REVENUE BY COUNTRY 31
3.6.3 MEXICO 32
3.6.4 BRAZIL 32
3.6.5 ARGENTINA 33
3.7 MIDDLE EAST AND AFRICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY 33
3.7.1 MIDDLE EAST AND AFRICA VITAMIN K2 SALES BY COUNTRY 33
3.7.2 MIDDLE EAST AND AFRICA VITAMIN K2 REVENUE BY COUNTRY 34
3.7.3 TURKEY 35
3.7.4 SAUDI ARABIA 35
3.7.5 UAE 36
4 VITAMIN K2 HISTORIC MARKET ANALYSIS BY TYPE 37
4.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY TYPE (2017-2022) 37
4.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY TYPE (2017-2022) 38
4.3 GLOBAL VITAMIN K2 PRICE BY TYPE (2017-2022) 38
5 VITAMIN K2 HISTORIC MARKET ANALYSIS BY APPLICATION 39
5.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY APPLICATION (2017-2022) 39
5.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY APPLICATION (2017-2022) 39
5.3 GLOBAL VITAMIN K2 PRICE BY APPLICATION (2017-2022) 40
6 KEY COMPANIES PROFILED 41
6.1 GNOSIS BY LESAFFRE 41
6.1.1 GNOSIS CORPORATION INFORMATION 41
6.1.2 GNOSIS DESCRIPTION AND BUSINESS OVERVIEW 41
6.1.3 GNOSIS VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 42
6.1.4 GNOSIS VITAMIN K2 PRODUCT PORTFOLIO 42
6.1.5 GNOSIS RECENT DEVELOPMENTS/UPDATES 44
6.2 KAPPA BIOSCIENCE 45
6.2.1 KAPPA BIOSCIENCE CORPORATION INFORMATION 45
6.2.2 KAPPA BIOSCIENCE DESCRIPTION AND BUSINESS OVERVIEW 45
6.2.3 KAPPA BIOSCIENCE VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 46
6.2.4 KAPPA BIOSCIENCE VITAMIN K2 PRODUCT PORTFOLIO 46
6.2.5 KAPPA BIOSCIENCE RECENT DEVELOPMENTS/UPDATES 47
6.3 GUANDONG SUNGEN 47
6.3.1 GUANDONG SUNGEN CORPORATION INFORMATION 48
6.3.2 GUANDONG SUNGEN DESCRIPTION AND BUSINESS OVERVIEW 48
6.3.3 GUANDONG SUNGEN VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 49
6.3.4 GUANDONG SUNGEN VITAMIN K2 PRODUCT PORTFOLIO 49
6.3.5 GUANDONG SUNGEN RECENT DEVELOPMENTS/UPDATES 49
6.4 VIRIDIS BIOPHARMA 50
6.4.1 VIRIDIS BIOPHARMA CORPORATION INFORMATION 50
6.4.2 VIRIDIS BIOPHARMA DESCRIPTION AND BUSINESS OVERVIEW 51
6.4.3 VIRIDIS BIOPHARMA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 51
6.4.4 VIRIDIS BIOPHARMA VITAMIN K2 PRODUCT PORTFOLIO 52
6.5 IFF HEALTH (FRUTAROM) 52
6.5.1 FRUTAROM CORPORATION INFORMATION 52
6.5.2 FRUTAROM DESCRIPTION AND BUSINESS OVERVIEW 53
6.5.3 FRUTAROM VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 53
6.5.4 FRUTAROM VITAMIN K2 PRODUCT PORTFOLIO 54
6.6 VESTA NUTRA 54
6.6.1 VESTA NUTRA CORPORATION INFORMATION 55
6.6.2 VESTA NUTRA DESCRIPTION AND BUSINESS OVERVIEW 55
6.6.3 VESTA NUTRA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 55
6.6.4 VESTA NUTRA VITAMIN K2 PRODUCT PORTFOLIO 56
6.7 GENEFERM BIOTECHNOLOGY 56
6.7.1 GENEFERM BIOTECHNOLOGY CORPORATION INFORMATION 56
6.7.2 GENEFERM BIOTECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW 57
6.7.3 GENEFERM BIOTECHNOLOGY VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 57
6.7.4 GENEFERM BIOTECHNOLOGY VITAMIN K2 PRODUCT PORTFOLIO 58
6.8 SHANGHAI RESON BIOTECH 58
6.8.1 SHANGHAI RESON BIOTECH CORPORATION INFORMATION 59
6.8.2 SHANGHAI RESON BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 59
6.8.3 SHANGHAI RESON BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 59
6.8.4 SHANGHAI RESON BIOTECH VITAMIN K2 PRODUCT PORTFOLIO 60
6.9 GUANGDONG GOODSCEND 61
6.9.1 GUANGDONG GOODSCEND CORPORATION INFORMATION 61
6.9.2 GUANGDONG GOODSCEND DESCRIPTION AND BUSINESS OVERVIEW 61
6.9.3 GUANGDONG GOODSCEND VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 62
6.9.4 GUANGDONG GOODSCEND VITAMIN K2 PRODUCT PORTFOLIO 62
6.10 SEEBIO BIOTECH 63
6.10.1 SEEBIO BIOTECH CORPORATION INFORMATION 64
6.10.2 SEEBIO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 64
6.10.3 SEEBIO BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 64
6.10.4 SEEBIO BIOTECH VITAMIN K2 PRODUCT PORTFOLIO 65
6.11 KYOWA HAKKO 66
6.11.1 KYOWA HAKKO CORPORATION INFORMATION 66
6.11.2 KYOWA HAKKO DESCRIPTION AND BUSINESS OVERVIEW 67
6.11.3 KYOWA HAKKO VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022) 67
6.11.4 KYOWA HAKKO VITAMIN K2 PRODUCT PORTFOLIO 67
7 VITAMIN K2 MANUFACTURING COST ANALYSIS 69
7.1 VITAMIN K2 KEY RAW MATERIALS ANALYSIS 69
7.1.1 KEY RAW MATERIALS 69
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 69
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 71
7.3 MANUFACTURING PROCESS ANALYSIS OF VITAMIN K2 72
7.4 VITAMIN K2 INDUSTRIAL CHAIN ANALYSIS 73
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 74
8.1 MARKETING CHANNEL 74
8.2 VITAMIN K2 DISTRIBUTORS LIST 74
8.3 VITAMIN K2 CUSTOMERS 76
9 VITAMIN K2 MARKET DYNAMICS 79
9.1 VITAMIN K2 INDUSTRY TRENDS 79
9.2 VITAMIN K2 MARKET DRIVERS 79
9.3 VITAMIN K2 MARKET CHALLENGES 80
9.4 VITAMIN K2 MARKET RESTRAINTS 80
10 GLOBAL MARKET FORECAST 81
10.1 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY TYPE 81
10.1.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY TYPE (2023-2028) 81
10.1.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY TYPE (2023-2028) 81
10.2 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 82
10.2.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY APPLICATION (2023-2028) 82
10.2.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY APPLICATION (2023-2028) 82
10.3 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY REGION 83
10.3.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY REGION (2023-2028) 83
10.3.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY REGION (2023-2028) 83
11 RESEARCH FINDINGS AND CONCLUSION 85
12 METHODOLOGY AND DATA SOURCE 87
12.1 METHODOLOGY/RESEARCH APPROACH 87
12.1.1 RESEARCH PROGRAMS/DESIGN 87
12.1.2 MARKET SIZE ESTIMATION 88
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 89
12.2 DATA SOURCE 90
12.2.1 SECONDARY SOURCES 90
12.2.2 PRIMARY SOURCES 91
12.3 AUTHOR LIST 93
12.4 DISCLAIMER 93

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630